Shaping the future of cardiology - A journey of meaningful innovation in structural heart and coronary

Sponsored by Meril

Anchorperson: A. Zaman

Spokesperson: F. Sawaya

Summary

This EuroPCR 2025 session highlights the latest device innovations reshaping interventional cardiology. Learn how the Myval OCTAPRO THV combines predictable deployment with minimal foreshortening for improved outcomes in structural heart procedures. In the coronary space, the session explores the renewed appeal of the “leave nothing behind” philosophy through novel bioresorbable scaffolds and sirolimus-coated balloons. You’ll also hear about practical applications of dedicated bifurcation and tapered stents, and gain insights into the ultra-thin strut Evermine50™ DES platform, now under evaluation in the SORT OUT XII DAPT trial. From device design to clinical practice, explore how these technologies are paving the way for safer, more durable outcomes in complex interventions.

Learning Objectives

To discover more about the concept of leaving nothing behind with thin strut BRS platform and sirolimus DCB
To learn about the relevance of dedicated bifurcation and long tapered stents in managing complex PCI
To understand ultra thin strut DES platform and its clinical benefits